Zobrazeno 1 - 8
of 8
pro vyhledávání: '"John A. Germak"'
Publikováno v:
Journal of Neuroendocrinology. 9:467-478
The immortalized neuronal cell line, GT1-7, has been shown to secrete LHRH in a pulsatile manner and to possess many other characteristics of hypothalamic LHRH neurons in vivo, and thus provides a potential model system for studying biochemical and p
Autor:
John A Germak, Sasigarn A. Bowden
Publikováno v:
Journal of Pediatric Endocrinology and Metabolism. 19
Publikováno v:
Clinical Pediatrics. 33:232-234
Pediatric patients with insulin-dependent diabetes mellitus were surveyed over a 5-month period to determine disposal practices of insulin syringes. Eighty-nine (79.5%) of 112 patients surveyed responded. Thirty-three percent of the responders dispos
Autor:
George R. Buchanan, John A. Germak, Kevin C. Oeffinger, Gail E. Tomlinson, Laura E. Snell, Thomas C. Andrews, Debra A. Eshelman, Barbara M. Foster, Margo A. Denke
Publikováno v:
Journal of pediatric hematology/oncology. 23(7)
Purpose To assess cardiovascular risk factors (CVRF) in young adult survivors of childhood acute lymphoblastic leukemia (ALL). Patients and methods Twenty-six subjects (median age, 20.9 years; median interval since completion of therapy, 13.3 years)
Publikováno v:
Neuroendocrinology. 64(4)
Increased gap junctional intercellular communication induced by agents that stimulate the adenylyl cyclase/cAMP pathway was observed in the GnRH-secreting neuronal cell line, GT1-7, and possible underlying mechanisms were examined. A 24-hour treatmen
Autor:
John A. Germak
Publikováno v:
Indian journal of pediatrics. 63(5)
The introduction of recombinant DNA-synthesized human growth hormone in the mid-1980s, and its attendant unlimited supply, have led to wider application of growth hormone therapy in children. Over the past decade, the efficacy of growth hormone treat
Autor:
John A. Germak, Thomas P. Foley
Publikováno v:
The Journal of pediatrics. 117(2 Pt 1)
We evaluated the longitudinal response in 43 infants with congenital primary hypothyroidism during the first year of L-thyroxine therapy. Diagnosis was confirmed by serum thyroid hormone measurements by 4 weeks of age in 38 infants and between 40 and